| Title |
|
Beta-Lactam and Sulfonamide Allergy Testing Should Be a Standard of Care in Immunocompromised Host. |
|
|
| Publication Date |
|
| Author(s) |
|
| Subject |
|
Antibiotic allergy testing |
|
|
Penicillin allergy testing |
|
|
| Type of document |
|
| OrcId |
|
| DOI |
|
10.1016/j.jaip.2019.05.051 |
|
|
| Abstract |
|
Antibiotic allergies are reported in up to 1 in 4 immunocompromised hosts with significant impacts on antibiotic utilization and patient outcomes. Health services programs focused on de-labeling beta-lactam and sulfonamide allergy labels should be a standard of care in immunocompromised hosts. |
|
|
| Link |
|
| Citation |
|
The Journal of Allergy and Clinical Immunology. In Practice 2019; 7(7): 2151-2153 |
|
|
| Jornal Title |
|
The Journal of Allergy and Clinical Immunology. In Practice |
|
|
